The Past, Present and Future of Non-Target Screening
Thomas Letzel reflects on the evolution of non-target screening and why interdisciplinary insights are key to its future
Clinical Scorecard: The Past, Present and Future of Non-Target Screening
At a Glance
| Category | Detail |
|---|
| Condition | Non-Target Screening (NTS) |
| Key Mechanisms | Mass spectrometry (MS) coupled with chromatographic separation systems for analyzing unknown compounds. |
| Target Population | Researchers and laboratories across environmental science, metabolomics, food analysis, and industrial processes. |
| Care Setting | Laboratories implementing non-target screening methodologies. |
Key Highlights
- NTS is evolving with a focus on data handling and interpretation.
- It is well established in metabolomics and environmental water analysis.
- AFIN-TS aims to support laboratories in implementing NTS.
- Machine learning and data management platforms are critical for NTS advancement.
- Collaboration across disciplines enhances the effectiveness of NTS.
Guideline-Based Recommendations
Diagnosis
- Utilize mass spectrometry for identifying unknown compounds.
Management
- Implement holistic NTS data management platforms for data storage and evaluation.
Monitoring & Follow-up
- Regularly update and maintain machine-readable data for retrospective analysis.
Risks
- Challenges include sustainable data storage and the need for robust data processing.
Patient & Prescribing Data
Not applicable; focuses on laboratory and research settings.
NTS can identify unknown substances in various fields, enhancing safety and compliance.
Clinical Best Practices
- Encourage interdisciplinary collaboration to enhance NTS applications.
- Provide training and education on NTS methodologies for laboratory personnel.
- Utilize robust analytical techniques and workflows for reliable results.
References
